Stocks › HAE
HAEMONETICS CORP
HAE·NYSE·
United States·USD
$120.16
-0.21 (-0.17%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
HAE
HAEMONETICS CORP · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HAES&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of HAE by members of U.S. Congress · 17 on record
Whale Activity
Position changes in HAE reported for 2026-09-30 by 393 institutional filers
- Increased107
- New61
- Held45
- Decreased130
- Closed32
- No prior filing18
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 6.0M | $626.9M | increased |
| Neuberger Berman Group LLC | 3.5M | $366.7M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5M | $263.4M | decreased |
| ARIEL INVESTMENTS, LLC | 2.2M | $228.9M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $215.4M | decreased |
| AQR CAPITAL MANAGEMENT LLC | 1.8M | $189.5M | decreased |
| STATE STREET CORP | 1.8M | $189.4M | decreased |
| CITADEL ADVISORS LLC | 1.7M | $175.1M | increased |
| T. Rowe Price Investment Management, Inc. | 1.4M | $150.3M | increased |
| GOLDMAN SACHS GROUP INC | 1.4M | $144.1M | increased |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | $134.8M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $131.2M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by HAE insiders, by quarter · Form 4
Recent Insider Transactions
1,860 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Sale | −836 | $120.99 | $101K | Nov 11, 2026 | Form 4 ↗ |
| Madaus Martin DDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| Zane Ellen MDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| Pomeroy ClaireDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| KROLL MARK WDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| Johnson Lloyd EmersonDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| COYLE MICHAEL JDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| Bryant Diane MDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| ABERNATHY ROBERT EDirector | Grant / award | +2,538 | — | — | Jul 24, 2026 | Form 4 ↗ |
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Tax withholding | −259 | $71.28 | $18K | Jun 5, 2026 | Form 4 ↗ |
| Miller Laurie A.SVP, Human Resources | Tax withholding | −313 | $71.28 | $22K | Jun 5, 2026 | Form 4 ↗ |
| Basil Michelle LEVP and General Counsel | Grant / award | +28.4K | — | — | May 15, 2026 | Form 4 ↗ |
| Basil Michelle LEVP and General Counsel | Tax withholding | −2,913 | $56.29 | $164K | May 15, 2026 | Form 4 ↗ |
| Chan FrankEVP, Chief Operating Officer | Grant / award | +27.5K | — | — | May 15, 2026 | Form 4 ↗ |
| Chan FrankEVP, Chief Operating Officer | Tax withholding | −546 | $56.29 | $31K | May 15, 2026 | Form 4 ↗ |
| DArecca JamesEVP, Chief Financial Officer | Grant / award | +29.3K | — | — | May 15, 2026 | Form 4 ↗ |
| DArecca JamesEVP, Chief Financial Officer | Tax withholding | −2,505 | $56.29 | $141K | May 15, 2026 | Form 4 ↗ |
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Grant / award | +2,220 | — | — | May 15, 2026 | Form 4 ↗ |
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Tax withholding | −197 | $56.29 | $11K | May 15, 2026 | Form 4 ↗ |
| Galvin RoyEVP, Chief Commercial Officer | Grant / award | +27.5K | — | — | May 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding HAE · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Neuberger Genesis Fund NEUBERGER BERMAN EQUITY FUNDS | 1.2M | $124.1M | 1.71% | Aug 31, 2026 |
| iShares Core S&P Mid-Cap ETF iShares Trust | 1.6M | $119.2M | 0.10% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.4M | $108.1M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.2M | $92.0M | 0.11% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.0M | $78.1M | 0.04% | Jun 30, 2026 |
| Ariel Fund Ariel Investment Trust | 573.7K | $60.4M | 2.18% | Sep 30, 2026 |
| Touchstone Strategic Trust-Touchstone Small Company Fund Touchstone Strategic Trust | 614.8K | $46.1M | 2.68% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 515.3K | $44.1M | 0.13% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 533.2K | $40.0M | 0.04% | Jun 30, 2026 |
| Neuberger Intrinsic Value Fund NEUBERGER BERMAN EQUITY FUNDS | 364.1K | $37.5M | 2.62% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list HAE's shares (CUSIP 405024100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- AQR Capital Management Holdings, LLCSCHEDULE 13G/A · passive (13G) · 2.3M shares5.0%
Aug 12, 2026 · ↗ - AQR Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 2.3M shares5.0%
Aug 12, 2026 · ↗ - Jeremy Steven KahanSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - Michael Kevin KahanSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Ultra Fund, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Alpha Fund, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Partners II, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Partners, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital GP, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming HAEMONETICS CORP as client
No lobbying filings found naming HAEMONETICS CORP as the client.
Government Contracts
Federal awards to haemonetics · USAspending
$480KAwarded · 10 contracts on record
- Department of Veterans AffairsEXPRESS REPORT NX ORDERS PLACED DURING THE MONTH OF OCTOBER, 2026$24K
Oct 1, 2026 · ↗ - Department of Veterans AffairsTEG6 PLATINUM SERVICE$12K
Sep 16, 2024 · ↗ - Department of Veterans AffairsTEG ANALYZERS$24K
Oct 10, 2024 · ↗ - Department of DefenseVASCADE MVP.$84K
Jun 2, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF AUGUST, 2026$27K
Aug 1, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF APRIL, 2026$23K
Apr 1, 2026 · ↗ - Department of DefenseHAEMONETICS CORPORATION PROVIDES THE ARTERIAL AND VENOUS CLOSURE SHEATHS REQUIRED FOR CARDIAC ELECTROPHYSIOLOGY PROCEDURES WHICH ENABLE SAME$88K
Feb 12, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF FEBRUARY 2026$50K
Feb 1, 2026 · ↗
U.S. Patents
Recent USPTO applications naming HAEMONETICS CORP
No USPTO patent applications found for HAEMONETICS CORP.
Annual Financials
From HAE's 10-K filings · XBRL
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993.2M |
| Operating income | $156.7M | $221.8M | $164.9M | $156.0M | $80.8M |
| Net income | $97.3M | $167.7M | $117.6M | $115.4M | $43.4M |
| Diluted EPS | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
| Operating cash flow | $293.2M | $181.7M | $181.8M | $273.1M | $172.3M |
| Cash and equivalents | $245.4M | $306.8M | $178.8M | $284.5M | $259.5M |
| Total assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B |
| Shareholders' equity | $796.3M | $820.8M | $960.0M | $818.0M | $749.4M |
As HAEMONETICS CORP tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed May 20, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitDec 3, 2012
- 2-for-1Stock splitJan 11, 1993
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
EDGAR ↗ - 8-K · Items 7.01Reg FD disclosureOct 8, 2026
EDGAR ↗ - 8-K · Items 7.01Reg FD disclosureAug 18, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJul 28, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJun 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeMay 1, 2026
EDGAR ↗
About HAEMONETICS CORP
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersBOSTON, MA
IncorporatedMA
SEC CIK0000313143 ↗




